ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
We have found contact information containing phone numbers and email addresses for Imclone Systems, A Wholly-Owned Subsidiary Of Eli Lilly And Company. Imclone Systems, A Wholly-Owned Subsidiary Of Eli Lilly And Company operates in the Biotechnology industry. The company operates in the fields of Monoclonal antibodies and biopharmaceutical company.
Company Details
Last Update
Jul 14, 2022
Industry
Biotechnology
Specialties
Monoclonal antibodies
biopharmaceutical company
Founded
9184
Number of Employee
1001-5000 employees
NAICS
623 - Nursing and Residential Care Facilities
Decision Makers
Assistant General Patent Counsel
Chief Marketing Officer | Head Of Marketing | Oncology
Employees
Director, Global Commercial Strategy - Rheumatology
Associate Director, Clinical Operations Lead, Oncology Assets
Microbiology Manager
Executive Director, R And D Clinical Contracting And Category Management
Tmf Director, Clinical Operations
Director Of Engineering
Independent Medical Education Manager
Vice President Of Legal, Americas And Europe
Vice President
Pharmaceuticals
FAQs about ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
In what industry does Imclone Systems, A Wholly-Owned Subsidiary Of Eli Lilly And Company operate?
Imclone Systems, A Wholly-Owned Subsidiary Of Eli Lilly And Company operates in the field of Biotechnology.
What are special fields for Imclone Systems, A Wholly-Owned Subsidiary Of Eli Lilly And Company?
The specialties for Imclone Systems, A Wholly-Owned Subsidiary Of Eli Lilly And Company are Monoclonal antibodies and biopharmaceutical company